Adalimumab for the treatment of Crohn’s disease
Open Access
- 1 September 2008
- journal article
- Published by Taylor & Francis in Biologics: Targets and Therapy
- Vol. 2 (4) , 763-77
Abstract
Peer reviewed article authored by (Andrea Cassinotti, Sandro Ardizzone, Gabriele Bianchi Porro). Read article or submit your manuscript for publishing.Keywords
This publication has 60 references indexed in Scilit:
- Adalimumab for the treatment of Crohn‐like colitis and enteritis in glycogen storage disease type IbJournal of Inherited Metabolic Disease, 2008
- The use of adalimumab in the management of refractory Crohn’s diseaseAlimentary Pharmacology & Therapeutics, 2007
- Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trialGut, 2007
- Efficacy and safety of short‐term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open‐label, multicentre trialAlimentary Pharmacology & Therapeutics, 2007
- Adalimumab in patients with Crohn’s disease – safety and efficacy in an open‐label single centre studyAlimentary Pharmacology & Therapeutics, 2007
- Crohn’s DiseaseDrugs, 2007
- The Successful Use of Adalimumab to Treat Active Crohn's Disease of an Ileoanal Pouch During PregnancyDigestive Diseases and Sciences, 2006
- Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumabAnnals of the Rheumatic Diseases, 2006
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Biologic Therapy for Inflammatory Bowel DiseaseDrugs, 2005